|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,983.00 GBX | -1.59% |
|
+0.18% | +8.69% |
| 12:08am | Stocks mixed as weak miners weigh in muted trade | AN |
| 08:33pm | HSBC Upgrades GSK to Hold Rating, Boosts PT | MT |
| Market Cap | 80.29B 107B 93.91B 86.5B 152B 10,229B 155B 1,035B 403B 5,021B 403B 394B 17,408B | P/E 2026 * |
12.9x | P/E 2027 * | 11.9x |
|---|---|---|---|---|---|
| Enterprise Value | 95.72B 128B 112B 103B 182B 12,195B 184B 1,234B 480B 5,986B 480B 470B 20,754B | EV / Sales 2026 * |
2.83x | EV / Sales 2027 * | 2.6x |
| Free-Float |
92.29% | Yield 2026 * |
3.46% | Yield 2027 * | 3.64% |
Last Transcript: GSK plc
| 08:33pm | HSBC Upgrades GSK to Hold Rating, Boosts PT | MT |
| 04:44pm | HSBC raises GSK; RBC cuts Close Brothers | AN |
| 06-30 | UBS, RBC and Citi cut easyJet; UBS lowers Mondi | AN |
| 06-30 | GSK : Goldman Sachs gives a Neutral rating | ZD |
| 06-30 | GSK : Sell rating from Barclays | ZD |
| 1 day | -1.61% | ||
| 1 week | +0.18% | ||
| Current month | +0.10% | ||
| 1 month | +3.66% | ||
| 3 months | -5.39% | ||
| 6 months | +4.40% | ||
| Current year | +8.69% |
| 1 week | 1,930 |  | 2,048.98 |
| 1 month | 1,839 | | 2,048.98 |
| Current year | 1,690 | | 2,282 |
| 1 year | 1,288.6 | | 2,282 |
| 3 years | 1,242.5 | | 2,282 |
| 5 years | 1,242.5 | | 3,408.16 |
| 10 years | 1,242.5 | | 3,408.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Luke Miels
CEO | Chief Executive Officer | - | 01/01/2026 |
Julie Brown
DFI | Director of Finance/CFO | 64 | 01/05/2023 |
| Chief Tech/Sci/R&D Officer | - | 01/12/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Luke Miels
BRD | Director/Board Member | - | 06/05/2026 |
Hal Barron
BRD | Director/Board Member | 64 | 01/01/2018 |
Jonathan Symonds
CHM | Chairman | 68 | 01/09/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-22 | Buy | Executive/Senior Manager | 9 | 0.0000% | ||
| 06-08 | Buy | Executive/Senior Manager | 9 | 0.0000% | ||
| 05-22 | Buy | Executive/Senior Manager | 9 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.59% | +0.18% | +42.10% | +48.34% | 107B | |
| -0.75% | -2.08% | +55.83% | +160.00% | 1,082B | |
| -1.35% | +0.10% | +66.66% | +60.13% | 633B | |
| -2.00% | +0.54% | +36.27% | +86.30% | 461B | |
| -2.79% | +1.37% | +31.00% | +23.05% | 338B | |
| -2.46% | -1.38% | +37.99% | +36.52% | 299B | |
| -2.20% | -0.87% | +28.16% | +42.69% | 291B | |
| -1.77% | +1.97% | -27.22% | -40.66% | 222B | |
| -1.91% | +1.74% | +25.22% | +64.52% | 202B | |
| -1.43% | +2.28% | +15.59% | +69.47% | 163B | |
| Average | -1.87% | +4.17% | +31.16% | +55.04% | 379.96B | |
| Weighted average by Cap. | -1.65% | +5.32% | +40.94% | +79.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 33.86B 45.22B 39.6B 36.48B 64.3B 4,314B 65.17B 437B 170B 2,117B 170B 166B 7,341B | 35.58B 47.52B 41.62B 38.33B 67.57B 4,533B 68.49B 459B 179B 2,225B 178B 175B 7,715B |
| Net income | 6.47B 8.64B 7.57B 6.97B 12.29B 824B 12.45B 83.45B 32.48B 405B 32.46B 31.74B 1,403B | 6.94B 9.26B 8.11B 7.47B 13.17B 884B 13.35B 89.44B 34.81B 434B 34.78B 34.02B 1,504B |
| Net Debt | 15.43B 20.61B 18.05B 16.63B 29.31B 1,966B 29.7B 199B 77.46B 965B 77.4B 75.71B 3,346B | 12.24B 16.35B 14.32B 13.19B 23.24B 1,559B 23.56B 158B 61.43B 765B 61.39B 60.04B 2,654B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/07/26 | GBX 1,983.00 | -1.59% | 4,017,831 |
| 03/07/26 | GBX 2,015.00 | +0.55% | 2,548,759 |
| 02/07/26 | GBX 2,004.00 | +3.83% | 17,567,408 |
| 01/07/26 | GBX 1,930.00 | -2.57% | 8,818,924 |
| 30/06/26 | GBX 1,981.00 | +0.08% | 13,958,407 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GSK Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
